Skip to main content
Sanofi
Healthcare · Drug Manufacturers - General
Made on Jul 8, 2026
Price at call $42.98
6-month call Bull +39.9%
Target by Jan 2027 $60.11
Great value below $45.00
Model v0.3.0

Projection vs Actual (6M history + forecast)

Our straight 6-month prediction (bold) with a textured realism line, and the actual price overlaid from the prediction date forward.

Forecast

One directional 6-month call and the six monthly points we'll be scored against. Predicted Jul 8, 2026 4:16 am
Bull SNY trends higher to $60.11 (+39.9% from $42.98) by Jan 2027.
Monthmonths after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $42.98 at call
Prediction made Jul 8, 2026 $42.98 at call
M1 Aug 8, 2026 $45.84 +6.6%
What actually happened: closed $43.50 on Aug 7, 2026 = +1.2% vs the call (predicted +6.7%)  ·  direction MISS (called up, was flat)  ·  off by 5.4 pp  ·  accuracy 4/10  ·  S&P +3.7% over the same window — lagged it
M2 Sep 8, 2026 $48.69 +13.3%
M3 Oct 8, 2026 $51.55 +19.9%
M4 Nov 8, 2026 $54.40 +26.6%
M5 Dec 8, 2026 $57.26 +33.2%
M6 Jan 8, 2027 $60.11 +39.9%

Deserved value (DCF/composite) is $89.41; over 6 months we project closing only part-way to it (reach 36.9%). Value-only — see Not Yet Modeled below.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.3.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$42.98
Composite fair value$69.98
Signal-adjusted fair value$80.01
DCF fair value$95.60
Anchored-PE fair value$53.74
Buy-below (value lens)$45.00
Value net score+63
Value confidence7 / 10
Quality net score+40
Memo confidence7 / 10
Deserved value (base)$82.79
Quality tilt+8%
Deserved value (used)$89.41
Coherence (value × quality)1.00

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 29.3%  3m 26.8%  6m 25.7%  
Daily σ (realism noise)1.7%
Beta vs S&P 500 1m 0.15  3m 0.41  5m 0.44  
Trailing 6-month return-10.9%

Knobs (equation params)

Deserved wt · DCF0.5
Quality tilt cap (±)0.2
Horizon reach (6mo)0.45
Coherence floor (conflict)0.5
Conviction gain / pt0.06
Realism mean-reversion φ0.85
Conviction floor0.4
Deserved wt · composite0.5
Realism vol window3m
Neutral band (%)5
Horizon (months)6
Realism σ fallback0.015

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.3.0 #6bd904191719

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 8, 2026 freshest SNY-20260708-030001-27e5
ext-forensic-memo Jul 8, 2026 freshest ext-SNY-20260708-035338-8142
ext-lens-quality Jul 8, 2026 freshest ext-SNY-20260708-035338-8142
ext-lens-value Jul 8, 2026 freshest ext-SNY-20260708-035338-8142
scenario-valuation Jul 8, 2026 freshest SNY-20260708-030001-27e5
valuation-synthesis Jul 8, 2026 freshest SNY-20260708-030001-27e5

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

4 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 1, 2026 v0.6.0 Bull $43.08 $51.25 +19.0% Feb 2027 view
Jul 25, 2026 v0.6.0 Bull $43.36 $47.80 +10.2% Jan 2027 view
Jul 24, 2026 v0.6.0 Bear $43.36 $38.50 -11.2% Jan 2027 view
Jul 8, 2026 v0.3.0 Bull $42.98 $60.11 +39.9% Jan 2027 viewing

Not Yet Modeled

What this v0.3.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Signal-adjusted fair value ($80.01) — the red-flag-adjusted anchor isn't the primary input yet (we use the raw DCF/composite blend, which double-counts DCF).
  • Recent momentum / drift — the line takes off straight; the trailing 6-month move (-10.9%) doesn't bend the slope.
  • Market beta — computed (1–5mo) for context but does not condition the path.
  • Earnings dates, catalysts, and known events — not modeled.
  • Macro regime & sector rotation — not modeled.
  • Horizon is a fixed 6-month assumption, not a modeled time-to-target.
  • Outcome scoring — predictions aren't yet graded against realized price once the evaluation date passes.